中国组织工程研究 ›› 2024, Vol. 28 ›› Issue (5): 804-812.doi: 10.12307/2024.243
• 生物材料综述 biomaterial review • 上一篇 下一篇
王嘉旎,陈俊宇
收稿日期:
2022-12-19
接受日期:
2023-03-15
出版日期:
2024-02-18
发布日期:
2023-08-17
通讯作者:
陈俊宇,副教授,硕士生导师,口腔疾病研究国家重点实验室,国家口腔疾病临床医学中心,四川大学华西口腔医院修复科,四川省成都市 610041
作者简介:
王嘉旎,女,2004年生,汉族,主要从事血管化组织工程学方向的研究。
基金资助:
Wang Jiani, Chen Junyu
Received:
2022-12-19
Accepted:
2023-03-15
Online:
2024-02-18
Published:
2023-08-17
Contact:
Chen Junyu, Associate professor, Master’s supervisor, State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Prosthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan Province, China
About author:
Wang Jiani, State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Prosthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan Province, China
Supported by:
摘要:
文题释义:
金属离子的成血管活性:部分金属离子,如铜、镁离子等,可通过上调血管内皮生长因子的表达等途径调控血管生成,从而促进血管化的过程。金属离子的成血管活性受到其浓度的影响,不同浓度的金属离子对于血管生成的作用存在较大差异,高浓度的金属离子一般具有细胞毒性,而低浓度的金属离子具有成血管效应。
背景:多种金属离子因具有良好的血管生成活性,并参与成骨中血管新生等生理过程,在骨组织工程领域的研究和应用正日益深入。
目的:系统性阐释铜(Cu2+)、镁(Mg2+)、锶(Sr2+)、锌(Zn2+)、钴(Co2+)离子的促血管生成机制及其在骨组织工程的应用现状和主要治疗的疾病类型。结果与结论:①金属离子可以通过作用于血管内皮生长因子、缺氧诱导因子、血管生成相关基因、内皮细胞以及对巨噬细胞进行免疫调节等途径调控血管生成。②铜、镁、锶、锌、钴等金属离子因具有显著的血管生成效应,常用于组织工程支架的性能改善,其中水凝胶、生物陶瓷和合成聚合物材料目前应用较为广泛,镁及其合金也因其优良的承重能力颇具优势,但这些材料均存在一些缺陷,目前暂时没有一种理想的骨替代材料。③不同的离子作用特点如下:铜具有抗菌、成血管和成骨等性能,主要用于感染及肿瘤等引起的骨缺损;镁、锌具有较强的生物降解性,需要对降解速率进行控制;镁具有腐蚀性,主要以合金形式应用;锌的成血管机制涉及较少;镁、锶用于治疗骨质疏松性骨缺损效果显著。④以上5种金属离子(铜、镁、锶、锌、钴)具有显著的促血管生成作用,也通过成血管来促进成骨,个别离子如铜离子具有杀菌作用,这些金属离子可以作为治疗肿瘤、骨质疏松症、感染和创伤等引起的骨缺损的新策略,但是目前的临床试验和产品的应用性研究相对不足。
https://orcid.org/0000-0002-6467-1941(王嘉旎);https://orcid.org/0000-0003-1717-5782(陈俊宇)
中国组织工程研究杂志出版内容重点:生物材料;骨生物材料;口腔生物材料;纳米材料;缓释材料;材料相容性;组织工程
中图分类号:
王嘉旎, 陈俊宇. 金属离子促血管生成机制及在骨组织工程中的应用[J]. 中国组织工程研究, 2024, 28(5): 804-812.
Wang Jiani, Chen Junyu. Angiogenesis mechanism of metal ions and their application in bone tissue engineering[J]. Chinese Journal of Tissue Engineering Research, 2024, 28(5): 804-812.
[1] XUE N, DING X, HUANG R, et al. Bone tissue engineering in the treatment of bone defects. Pharmaceuticals (Basel). 2022;15(7):879. [2] SALAMANCA E, HSU CC, HUANG HM, et al. Bone regeneration using a porcine bone substitute collagen composite in vitro and in vivo. Sci Rep. 2018;8(1):984. [3] SHEIKH Z, NAJEEB S, KHURSHID Z, et al. Biodegradable materials for bone repair and tissue engineering applications. Materials (Basel). 2015;8(9):5744-5794. [4] BARRALET J, GBURECK U, HABIBOVIC P, et al. Angiogenesis in calcium phosphate scaffolds by inorganic copper ion release. Tissue Eng Part A. 2009;15(7):1601-1609. [5] WANG L, ZOU D, ZHANG S, et al. Repair of bone defects around dental implants with bone morphogenetic protein/fibroblast growth factor-loaded porous calcium phosphate cement: a pilot study in a canine model. Clin Oral Implants Res. 2011;22(2):173-181. [6] SONG Y, WU H, GAO Y, et al. Zinc silicate/nano-hydroxyapatite/collagen scaffolds promote angiogenesis and bone regeneration via the p38 MAPK pathway in activated monocytes. ACS Appl Mater Interfaces. 2020;12(14):16058-16075. [7] LAI Y, LI Y, CAO H, et al. Osteogenic magnesium incorporated into PLGA/TCP porous scaffold by 3D printing for repairing challenging bone defect. Biomaterials. 2019;197:207-219. [8] LI S, CUI Y, LIU H, et al. Application of bioactive metal ions in the treatment of bone defects. J Mater Chem B. 2022;10(45):9369-9388. [9] DIOMEDE F, MARCONI GD, FONTICOLI L, et al. Functional relationship between osteogenesis and angiogenesis in tissue regeneration. Int J Mol Sci. 2020;21(9):3242. [10] WALMSLEY GG, RANSOM RC, ZIELINS ER, et al. Stem cells in bone regeneration. Stem Cell Rev Rep. 2016;12(5):524-529. [11] GOUDAR RK, VLAHOVIC G. Hypoxia, angiogenesis, and lung cancer. Curr Oncol Rep. 2008;10(4):277-282. [12] KALEBIC T, GARBISA S, GLASER B, et al. Basement membrane collagen: degradation by migrating endothelial cells. Science. 1983;221(4607):281-283. [13] GARLANDA C, DEJANA E. Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol. 1997;17(7):1193-1202. [14] PEPPER MS. Manipulating angiogenesis. From basic science to the bedside. Arterioscler Thromb Vasc Biol. 1997;17(4):605-619. [15] RYAN EJ, RYAN AJ, GONZALEZ-VAZQUEZ A, et al. Collagen scaffolds functionalised with copper-eluting bioactive glass reduce infection and enhance osteogenesis and angiogenesis both in vitro and in vivo. Biomaterials. 2019;197:405-416. [16] LI Y, SUN R, ZOU J, et al. Dual roles of the AMP-activated protein kinase pathway in angiogenesis. Cells. 2019;8(7):752. [17] PIZZICANNELLA J, GUGLIANDOLO A, ORSINI T, et al. Engineered extracellular vesicles from human periodontal-ligament stem cells increase VEGF/VEGFR2 expression during bone regeneration. Front Physiol. 2019;10:512. [18] EL-FIQI A, MANDAKHBAYAR N, JO SB, et al. Nanotherapeutics for regeneration of degenerated tissue infected by bacteria through the multiple delivery of bioactive ions and growth factor with antibacterial/angiogenic and osteogenic/odontogenic capacity. Bioact Mater. 2021;6(1):123-136. [19] GAO P, FAN B, YU X, et al. Biofunctional magnesium coated Ti6Al4V scaffold enhances osteogenesis and angiogenesis and for orthopedic application. Bioact Mater. 2020; 5(3):680-693. [20] KERMANI F, MOLLAZADEH BEIDOKHTI S, BAINO F, et al. Strontium- and cobalt-doped multicomponent mesoporous bioactive glasses (MBGs) for potential use in bone tissue engineering applications. Materials (Basel). 2020;13(6):1348. [21] KLING L, SCHREIBER A, ECKARDT KU, et al. Hypoxia-inducible factors not only regulate but also are myeloid-cell treatment targets. J Leukoc Biol. 2021;110(1):61-75. [22] CHOUDHRY H, HARRIS AL. Advances in hypoxia-inducible factor biology. Cell Metab. 2018;27(2):281-298. [23] SUN Y, LIU X, ZHU Y, et al. Tunable and controlled release of cobalt ions from metal-organic framework hydrogel nanocomposites enhances bone regeneration. ACS Appl Mater Interfaces. 2021;13(49):59051-59066. [24] SOLANKI AK, LALI FV, AUTEFAGE H, et al. Bioactive glasses and electrospun composites that release cobalt to stimulate the HIF pathway for wound healing applications. Biomater Res. 2021;25(1):1. [25] YAN J, XIA D, ZHOU W, et al. pH-responsive silk fibroin-based CuO/Ag micro/nano coating endows polyetheretherketone with synergistic antibacterial ability, osteogenesis, and angiogenesis. Acta Biomater. 2020;115:220-234. [26] ZHANG R, JIANG G, GAO Q, et al. Sprayed copper peroxide nanodots for accelerating wound healing in a multidrug-resistant bacteria infected diabetic ulcer. Nanoscale. 2021;13(37):15937-15951. [27] CIOFFI CL, LIU XQ, KOSINSKI PA, et al. Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem Biophys Res Commun. 2003;303(3):947-953. [28] XIAO X, XU S, LI L, et al. The Effect of velvet antler proteins on cardiac microvascular endothelial cells challenged with ischemia-hypoxia. Front Pharmacol. 2017;8:601. [29] DANG W, MA B, LI B, et al. 3D printing of metal-organic framework nanosheets-structured scaffolds with tumor therapy and bone construction. Biofabrication. 2020; 12(2):025005. [30] ZHANG J, WU H, HE F, et al. Concentration-dependent osteogenic and angiogenic biological performances of calcium phosphate cement modified with copper ions. Mater Sci Eng C Mater Biol Appl. 2019;99:1199-1212. [31] MAIER JAM, BERNARDINI D, RAYSSIGUIER Y, et al. High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochimica Et Biophysica Acta. 2004;1689(1):6-12. [32] ZICHE M, MORBIDELLI L. Nitric oxide and angiogenesis. J Neurooncol. 2000;50(1-2): 139-148. [33] XUE Y, ZHU Z, ZHANG X, et al. Accelerated bone regeneration by mof modified multifunctional membranes through enhancement of osteogenic and angiogenic performance. Adv Healthc Mater. 2021;10(6):e2001369. [34] YUNNA C, MENGRU H, LEI W, et al. Macrophage M1/M2 polarization. Eur J Pharmacol. 2020;877:173090. [35] LIU J, ZHAO Y, ZHANG Y, et al. Exosomes derived from macrophages upon Zn ion stimulation promote osteoblast and endothelial cell functions. J Mater Chem B. 2021;9(18):3800-3807. [36] ZHENG Z, CHEN Y, HONG H, et al. The “Yin and Yang” of immunomodulatory magnesium-enriched graphene oxide nanoscrolls decorated biomimetic scaffolds in promoting bone regeneration. Adv Healthc Mater. 2021;10(2):e2000631. [37] WU T, LIU W, HUANG S, et al. Bioactive strontium ions/ginsenoside Rg1-incorporated biodegradable silk fibroin-gelatin scaffold promoted challenging osteoporotic bone regeneration. Materials today Bio. 2021;12:100141. [38] YANG C, MA H, WANG Z, et al. 3D printed wesselsite nanosheets functionalized scaffold facilitates NIR-II photothermal therapy and vascularized bone regeneration. Adv Sci (Weinh). 2021;8(20):e2100894. [39] NAKASHIMA K, ZHOU X, KUNKEL G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002; 108(1):17-29. [40] XU R, YALLOWITZ A, QIN A, et al. Targeting skeletal endothelium to ameliorate bone loss. Nat Med. 2018;24(6):823-833. [41] HAN HS, JUN I, SEOK HK, et al. Biodegradable magnesium alloys promote angio-osteogenesis to enhance bone repair. Adv Sci (Weinh). 2020;7(15):2000800. [42] JAIDEV LR, KUMAR S, CHATTERJEE K. Multi-biofunctional polymer graphene composite for bone tissue regeneration that elutes copper ions to impart angiogenic, osteogenic and bactericidal properties. Colloids Surf B Biointerfaces. 2017;159:293-302. [43] ZHAO Z, LI G, RUAN H, et al. Capturing magnesium ions via microfluidic hydrogel microspheres for promoting cancellous bone regeneration. ACS Nano. 2021;15(8): 13041-13054. [44] XU Y, XU C, HE L, et al. Stratified-structural hydrogel incorporated with magnesium-ion-modified black phosphorus nanosheets for promoting neuro-vascularized bone regeneration. Bioact Mater. 2022;16:271-284. [45] WU X, TANG Z, WU K, et al. Strontium-calcium phosphate hybrid cement with enhanced osteogenic and angiogenic properties for vascularised bone regeneration. J Mater Chem B. 2021;9(30):5982-5997. [46] LIU X, SUN Y, SHEN J, et al. Strontium doped mesoporous silica nanoparticles accelerate osteogenesis and angiogenesis in distraction osteogenesis by activation of Wnt pathway. Nanomedicine. 2022;41:102496. [47] ZHU WQ, LI K, SU S, et al. Effects of Zinc ions released from Ti-NW-Zn surface on osteogenesis and angiogenesis and in an zebrafish model. Front Bioeng Biotechnol. 2022;10:848769. [48] CHEN S, MICHáLEK M, GALUSKOVá D, et al. Multi-targeted B and Co co-doped 45S5 bioactive glasses with angiogenic potential for bone regeneration. Mater Sci Eng C Mater Biol Appl. 2020;112:110909. [49] LI Y, XU T, TU Z, et al. Bioactive antibacterial silica-based nanocomposites hydrogel scaffolds with high angiogenesis for promoting diabetic wound healing and skin repair. Theranostics. 2020;10(11):4929-4943. [50] FU X, LIU P, ZHAO D, et al. Effects of nanotopography regulation and silicon doping on angiogenic and osteogenic activities of hydroxyapatite coating on titanium implant. Int J Nanomedicine. 2020;15:4171-4189. [51] ZHAO H, SHEN S, ZHAO L, et al. 3D printing of dual-cell delivery titanium alloy scaffolds for improving osseointegration through enhancing angiogenesis and osteogenesis. BMC Musculoskelet Disord. 2021;22(1):734. [52] DOLLWET HH, SORENSON JR. Roles of copper in bone maintenance and healing. Biol Trace Elem Res. 1988;18:39-48. [53] LI Y, LU Y, QIU B, et al. Copper-containing titanium alloys promote angiogenesis in irradiated bone through releasing copper ions and regulating immune microenvironment. Biomater Adv. 2022;139:213010. [54] STEWART PS, COSTERTON JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001; 358(9276):135-138. [55] DALECKI AG, HAEILI M, SHAH S, et al. Disulfiram and copper ions kill mycobacterium tuberculosis in a synergistic manner. Antimicrob Agents Chemother. 2015;59(8): 4835-4844. [56] FAúNDEZ G, TRONCOSO M, NAVARRETE P, et al. Antimicrobial activity of copper surfaces against suspensions of Salmonella enterica and Campylobacter jejuni. BMC Microbiol. 2004;4:19. [57] FAN L, KöRTE F, RUDT A, et al. Encapsulated vaterite-calcite CaCO(3) particles loaded with Mg(2+) and Cu(2+) ions with sustained release promoting osteogenesis and angiogenesis. Front Bioeng Biotechnol. 2022;10:983988. [58] ZHENG K, DAI X, LU M, et al. Synthesis of copper-containing bioactive glass nanoparticles using a modified Stöber method for biomedical applications. Colloids Surf B Biointerfaces. 2017;150:159-167. [59] GU Y, ZHANG J, ZHANG X, et al. Three-dimensional printed Mg-doped β-TCP bone tissue engineering scaffolds: effects of magnesium ion concentration on osteogenesis and angiogenesis in vitro. Tissue Eng Regen Med. 2019;16(4):415-429. [60] VERSCHUREN EHJ, HOENDEROP JGJ, PETERS DJM, et al. Tubular flow activates magnesium transport in the distal convoluted tubule. FASEB J. 2019;33(4):5034-5044. [61] ZHANG Y, XU J, RUAN YC, et al. Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats. Nat Med. 2016;22(10): 1160-1169. [62] CHAYA A, YOSHIZAWA S, VERDELIS K, et al. Fracture healing using degradable magnesium fixation plates and screws. J Oral Maxillofac Surg. 2015;73(2):295-305. [63] QIU L, ZHANG C, YANG X, et al. A SiO(2) layer on PEO-treated Mg for enhanced corrosion resistance and bone regeneration. Front Bioeng Biotechnol. 2022;10:1053944. [64] LIU C, REN Z, XU Y, et al. Biodegradable magnesium alloys developed as bone repair materials: a review. Scanning. 2018;2018:9216314. [65] ZHANG D, LI M, XU R, et al. Complementary and synergistic design of bi-layered double hydroxides modified magnesium alloy toward multifunctional orthopedic implants. Adv Healthc Mater. 2022;12(2):e2201367. [66] ZHAO Z, ZHANG J, YANG Z, et al. Biodegradation of HA and β-TCP ceramics regulated by T-cells. Pharmaceutics. 2022;14(9):1962. [67] QI D, SU J, LI S, et al. 3D printed magnesium-doped beta-TCP gyroid scaffold with osteogenesis, angiogenesis, immunomodulation properties and bone regeneration capability in vivo. Biomater Adv. 2022;136:212759. [68] CHEN R, CHEN HB, XUE PP, et al. HA/MgO nanocrystal-based hybrid hydrogel with high mechanical strength and osteoinductive potential for bone reconstruction in diabetic rats. J Mater Chem B. 2021;9(4):1107-1122. [69] MA L, CHENG S, JI X, et al. Immobilizing magnesium ions on 3D printed porous tantalum scaffolds with polydopamine for improved vascularization and osteogenesis. Mater Sci Eng C Mater Biol Appl. 2020;117:111303. [70] CANALIS E, HOTT M, DELOFFRE P, et al. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone. 1996;18(6):517-523. [71] BONNELYE E, CHABADEL A, SALTEL F, et al. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone. 2008;42(1):129-138. [72] BARON R, TSOUDEROS Y. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol. 2002;450(1):11-17. [73] LAVET C, MABILLEAU G, CHAPPARD D, et al. Strontium ranelate stimulates trabecular bone formation in a rat tibial bone defect healing process. Osteoporos Int. 2017; 28(12):3475-3487. [74] REGINSTER JY. Cardiac concerns associated with strontium ranelate. Expert Opin Drug Saf. 2014;13(9):1209-1213. [75] GE C, CHEN F, MAO L, et al. Strontium ranelate-loaded POFC/β-TCP porous scaffolds for osteoporotic bone repair. RSC Adv. 2020;10(15):9016-9025. [76] LEE NH, KANG MS, KIM TH, et al. Dual actions of osteoclastic-inhibition and osteogenic-stimulation through strontium-releasing bioactive nanoscale cement imply biomaterial-enabled osteoporosis therapy. Biomaterials. 2021;276:121025. [77] STEFANIDOU M, MARAVELIAS C, DONA A, et al. Zinc: a multipurpose trace element. Arch Toxicol. 2006;80(1):1-9. [78] LU T, ZHANG J, YUAN X, et al. Enhanced osteogenesis and angiogenesis of calcium phosphate cement incorporated with zinc silicate by synergy effect of zinc and silicon ions. Mater Sci Eng C Mater Biol Appl. 2021;131:112490. [79] VU AA, ROBERTSON SF, KE D, et al. Mechanical and biological properties of ZnO, SiO(2), and Ag(2)O doped plasma sprayed hydroxyapatite coating for orthopaedic and dental applications. Acta Biomater. 2019;92:325-335. [80] XIONG K, WU T, FAN Q, et al. Novel reduced graphene oxide/zinc silicate/calcium silicate electroconductive biocomposite for stimulating osteoporotic bone regeneration. ACS Appl Mater Interfaces. 2017;9(51):44356-44368. [81] WANG Z, WANG W, ZHANG X, et al. Modulation of osteogenesis and angiogenesis activities based on ionic release from Zn-Mg alloys. Materials (Basel). 2022;15(20):7117. [82] RANA NK, SINGH P, KOCH B. CoCl simulated hypoxia induce cell proliferation and alter the expression pattern of hypoxia associated genes involved in angiogenesis and apoptosis. Biol Res. 2019;52(1):12. [83] CHAI YC, MENDES LF, VAN GASTEL N, et al. Fine-tuning pro-angiogenic effects of cobalt for simultaneous enhancement of vascular endothelial growth factor secretion and implant neovascularization. Acta Biomater. 2018;72:447-460. [84] AMBIKA S, MANOJKUMAR Y, ARUNACHALAM S, et al. Biomolecular interaction, anti-cancer and anti-angiogenic properties of cobalt (III) schiff base complexes. Sci Rep. 2019;9(1):2721. [85] LIU G, WANG X, ZHOU X, et al. Modulating the cobalt dose range to manipulate multisystem cooperation in bone environment: a strategy to resolve the controversies about cobalt use for orthopedic applications. Theranostics. 2020;10(3):1074-1089. [86] PRESCHA A, ZABŁOCKA-SŁOWIŃSKA K, GRAJETA H. Dietary silicon and its impact on plasma silicon levels in the polish population. Nutrients. 2019;11(5):980. [87] QIN D, WANG N, YOU X-G, et al. Collagen-based biocomposites inspired by bone hierarchical structures for advanced bone regeneration: ongoing research and perspectives. Biomater Sci. 2022;10(2):318-353. [88] RONDANELLI M, FALIVA MA, PERONI G, et al. Silicon: A neglected micronutrient essential for bone health. Exp Biol Med (Maywood). 2021;246(13):1500-1511. [89] ZHOU Z, SHI Q, WANG J, et al. The unfavorable role of titanium particles released from dental implants. Nanotheranostics. 2021;5(3):321-332. [90] HU Q, LU R, LIU S, et al. 3D Printing GelMA/PVA interpenetrating polymer networks scaffolds mediated with CuO nanoparticles for angiogenesis. Macromol Biosci. 2022; 22(10):e2200208. [91] GRITSCH L, LIVERANI L, LOVELL C, et al. Polycaprolactone electrospun fiber mats prepared using benign solvents: blending with copper(II)-chitosan increases the secretion of vascular endothelial growth factor in a bone marrow stromal cell line. Macromol Biosci. 2020;20(3):e1900355. [92] QI H, WANG K, LI M, et al. Co-culture of BMSCs and HUVECs with simvastatin-loaded gelatin nanosphere/chitosan coating on Mg alloy for osteogenic differentiation and vasculogenesis. Int J Biol Macromol. 2021;193(Pt B):2021-2028. [93] CHENG S, LAN L, LI M, et al. Pure Mg-Al layered double hydroxide film on magnesium alloys for orthopedic applications. ACS omega. 2021;6(38):24575-24584. [94] LEMOS MC, KOTANKO P, CHRISTIE PT, et al. A novel EXT1 splice site mutation in a kindred with hereditary multiple exostosis and osteoporosis. J Clin Endocrinol Metab. 2005;90(9):5386-5392. [95] MATSUMOTO K, OGAWA H, NOZAWA S, et al. An analysis of osteoporosis in patients with hereditary multiple exostoses. Osteoporos Int. 2020;31(12):2355-2361. [96] SENTCHORDI-MONTANé L, BENITO-SANZ S, AZA-CARMONA M, et al. High prevalence of variants in skeletal dysplasia associated genes in individuals with short stature and minor skeletal anomalies. Eur J Endocrinol. 2021;185(5):691-705. [97] JOCHMANN K, BACHVAROVA V, VORTKAMP A. Heparan sulfate as a regulator of endochondral ossification and osteochondroma development. Matrix Biol. 2014; 34:55-63. [98] MCCORMICK C, LEDUC Y, MARTINDALE D, et al. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat Genet. 1998;19(2):158-161. [99] MATSUMOTO Y, MATSUMOTO K, IRIE F, et al. Conditional ablation of the heparan sulfate-synthesizing enzyme Ext1 leads to dysregulation of bone morphogenic protein signaling and severe skeletal defects. J Biol Chem. 2010;285(25):19227-19234. [100] ZAIDI M. Skeletal remodeling in health and disease. Nat Med. 2007;13(7):791-801. [101] NOZAWA S, INUBUSHI T, IRIE F, et al. Osteoblastic heparan sulfate regulates osteoprotegerin function and bone mass. JCI Insight. 2018;3(3):e89624. [102] PACIFICI M. Hereditary multiple exostoses: new insights into pathogenesis, clinical complications, and potential treatments. Curr Osteoporos Rep. 2017;15(3):142-152. [103] MUNDY C, YANG E, TAKANO H, et al. Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses. J Biol Chem. 2018;293(20):7703-7716. [104] MERY B, ESPENEL S, GUY JB, et al. Biological aspects of chondrosarcoma: Leaps and hurdles. Crit Rev Oncol Hematol. 2018;126:32-36. [105] RAJU KS, ALESSANDRI G, ZICHE M, et al. Ceruloplasmin, copper ions, and angiogenesis. J Natl Cancer Inst. 1982;69(5):1183-1188. [106] BANAI S, HAGGROTH L, EPSTEIN SE, et al. Influence of extracellular magnesium on capillary endothelial cell proliferation and migration. Circ Res. 1990;67(3):645-650. [107] KUWABARA K, OGAWA S, MATSUMOTO M, et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Sci U S A. 1995; 92(10):4606-4610. [108] CHEN YW, SHI GQ, DING YL, et al. In vitro study on the influence of strontium-doped calcium polyphosphate on the angiogenesis-related behaviors of HUVECs. J Mater Sci Mater Med. 2008;19(7):2655-2662. [109] GéRARD C, BORDELEAU LJ, BARRALET J, et al. The stimulation of angiogenesis and collagen deposition by copper. Biomaterials. 2010;31(5):824-831. [110] ZHANG D, LI Y, ZHU T, et al. Zinc supplementation results in improved therapeutic potential of bone marrow-derived mesenchymal stromal cells in a mouse ischemic limb model. Cytotherapy. 2011;13(2):156-164. [111] BI L, RAHAMAN MN, DAY DE, et al. Effect of bioactive borate glass microstructure on bone regeneration, angiogenesis, and hydroxyapatite conversion in a rat calvarial defect model. Acta Biomater. 2013;9(8):8015-8026. [112] FIELDING G, BOSE S. SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo. Acta Biomater. 2013;9(11):9137-9148. [113] QU Y, ZHUANG H, ZHANG M, et al. Bone cements for therapy and regeneration for minimally invasive treatment of neoplastic bone defects. J Mater Chem B. 2021;9(21): 4355-4364. [114] YU S, SUN T, LIU W, et al. PLGA cage-like structures loaded with Sr/Mg-doped hydroxyapatite for repairing osteoporotic bone defects. Macromol Biosci. 2022;22(8): e2200092. |
[1] | 杨玉芳, 杨芷姗, 段棉棉, 刘毅恒, 唐正龙, 王 宇. 促红细胞生成素在骨组织工程中的应用及前景[J]. 中国组织工程研究, 2024, 28(9): 1443-1449. |
[2] | 王姗姗, 舒 晴, 田 峻. 物理因子促进干细胞的成骨分化[J]. 中国组织工程研究, 2024, 28(7): 1083-1090. |
[3] | 张 娅, 牟秋菊, 王自林, 刘宏杰, 祝丽丽. 负载富血小板血浆的水凝胶促进糖尿病大鼠创面愈合[J]. 中国组织工程研究, 2024, 28(5): 690-696. |
[4] | 朱礼威, 王江玥, 白 丁. 纳米复合甲基丙烯酰明胶水凝胶在不同骨缺损环境中应用的价值[J]. 中国组织工程研究, 2024, 28(5): 753-758. |
[5] | 尹 彤, 杨吉垒, 李友瑞, 刘卓冉, 姜 明. 核壳结构纳米纤维在口腔组织再生中的应用[J]. 中国组织工程研究, 2024, 28(5): 766-770. |
[6] | 王业元, 杜易朗, 于德浩, 宁凤婷, 白 冰. 微弧氧化处理对医用金属生物活性的影响[J]. 中国组织工程研究, 2024, 28(5): 771-776. |
[7] | 刘安宏, 蔡萌萌, 韩 笑, 王战会. 医用镁合金元素选择的研究现状[J]. 中国组织工程研究, 2024, 28(5): 777-782. |
[8] | 杨雨晴, 陈志宇. 早期短暂M1巨噬细胞在骨组织工程中的作用及应用[J]. 中国组织工程研究, 2024, 28(4): 594-601. |
[9] | 龙智睿, 黄 雷, 肖 放, 王 琳, 王晓蓓. 骨组织工程中研究水凝胶微球的特征[J]. 中国组织工程研究, 2024, 28(3): 472-478. |
[10] | 徐 静, 吕慧欣, 鲍 鑫, 张 逸, 王一涵, 周延民. 近红外光响应水凝胶在组织工程领域的应用[J]. 中国组织工程研究, 2024, 28(3): 486-492. |
[11] | 高雪钰, 张文涛, 孙天泽, 张 警, 李忠海. 金属离子在骨组织工程中的应用[J]. 中国组织工程研究, 2024, 28(3): 439-444. |
[12] | 陈品叡, 裴锡波, 薛轶元. 磁响应水凝胶在骨组织工程中的作用与优势[J]. 中国组织工程研究, 2024, 28(3): 452-457. |
[13] | 潘成镇, 陈 锋, 林宗汉, 莫 坚, 张 驰, 韦沅汛, 韦宗波. 萜类中药单体调控核转录因子κB信号通路防治骨质疏松症的机制[J]. 中国组织工程研究, 2024, 28(14): 2234-2241. |
[14] | 翟浩嫣, 赵 圆, 范登莹, 刘春艳. 活性氧影响牙周炎发生发展及牙周组织再生[J]. 中国组织工程研究, 2024, 28(14): 2254-2260. |
[15] | 范永晶, 王 姝, 金武龙. 颌骨来源骨髓间充质干细胞成骨分化的特点、优势与应用[J]. 中国组织工程研究, 2024, 28(1): 100-106. |
1.1.6 检索策略 通过上述中、英文检索词在PubMed和中国知网数据库对主题进行检索,中文检索式为主题:(铜离子OR镁离子OR锶离子OR锌离子OR钴离子) and主题:(骨) and主题:(血管生成),PubMed数据库的英文检索式见图1。
1.1.7 检索文献量 初筛得到英文文献1 023篇,中文文献19篇。
1.3 文献质量评估和数据提取 利用计算机初筛得到文献1 042篇。其中中文文献19篇,英文文献1 023篇。根据阅读标题和摘要排除不相关和重复性文献,得125篇。经过全文阅读后,最终纳入PubMed数据库文献114篇、中国知网数据库文献0篇,见图2。
#br#
文题释义:
金属离子的成血管活性:部分金属离子,如铜、镁离子等,可通过上调血管内皮生长因子的表达等途径调控血管生成,从而促进血管化的过程。金属离子的成血管活性受到其浓度的影响,不同浓度的金属离子对于血管生成的作用存在较大差异,高浓度的金属离子一般具有细胞毒性,而低浓度的金属离子具有成血管效应。骨缺损通常可由创伤、肿瘤、感染及骨骼疾病等先天或后天因素引起。由于骨组织具有自我修复能力,较小的骨缺损可自行愈合。但在多数情况下,仅凭骨的自然愈合无法修复骨缺损,需要采取临床干预。临床上常用的自体骨具备成骨诱导能力和骨传导的特性,是治疗骨缺损的金标准[2]。然而,自体骨移植可能引起局部并发症,移植的新骨也可能自溶,修复效果较差。异体骨移植所需的材料更易获得,但由于存在免疫排斥风险,可能传染疾病,临床应用受限。因此,开发一种集微创、优良成血管和成骨效应、组织相容性、生物安全性、良好的物化性质于一体的诱导骨再生的新治疗策略势在必行。近年来,骨组织工程领域在骨替代生物材料上取得了重大的进展,极大地避免了其他骨替代物的潜在风险,具有广阔的应用前景。
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||